Objective To evaluate the muscle mass, elasticity, hardness, and blood flow perfusion of skeletal muscles in elderly patients using multimodal ultrasound, and analyse the diagnostic value of multimodal ultrasound for sarcopenia.
Methods Patients over 60 years old with sarcopenia and healthy elderly individuals were selected as the sarcopenia group and control group. Musculoskeletal ultrasound, virtual touch tissue imaging quantification, and power Doppler ultrasound were used to measure and score the muscle thickness, cross-sectional area, shear wave velocity, and blood flow energy signals of bilateral biceps and rectus femoris muscles, respectively. The diagnostic values of multimodal ultrasound parameters for sarcopenia were analyzed based on the relative skeletal muscle mass index results obtained by dual energy X-ray absorptiometry (DEXA).
Results A total of 73 study subjects were included, including 36 cases in the sarcopenia group and 37 cases in the control group. The age, biceps, and rectus femoris shear wave velocity of the sarcopenia group were significantly higher than those of the control group (P<0.05). The thickness, cross-sectional area, and blood flow energy signal scores of the biceps brachii and rectus femoris muscles were significantly lower than those of the control group (P<0.05). Among various multimodal ultrasound parameters, muscle shear wave velocity has the best diagnostic efficiency. The area under curve (AUC) of the receiver operating characteristic curve for shear wave velocity of biceps brachii was 0.96[95%CI (0.87, 0.98)], and the sensitivity and specificity for diagnosing muscle atrophy were 86.50% and 98.89%, respectively. The AUC of shear wave velocity of rectus femoris muscle was 0.91[95%CI (0.84, 0.95)], with sensitivity and specificity of 81.08% and 90.38%, respectively. The thickness, cross-sectional area, and blood flow energy signal score of the biceps brachii and rectus femoris muscles were positively correlated with DEXA results, while shear wave velocity was negatively correlated with DEXA results.
Conclusion Multimodal ultrasound technology can evaluate the morphological structure, biomechanics, and microcirculation status of skeletal muscles in the limbs of elderly people. It has good diagnostic value for sarcopenia, providing objective and multidimensional quantitative diagnostic indicators for early screening of sarcopenia.
1.Colleluori G, Villareal DT. Aging, obesity, sarcopenia and the effect of diet and exercise intervention[J]. Exp Gerontol, 2021, 155: 111561. DOI: 10.1016/j.exger.2021.111561.
2.陈长,刘辉,蔺阳刚,等. 肌少症在老年动脉粥样硬化性心血管疾病发病中的作用研究进展[J]. 解放军医学杂志, 2021, 46(5): 512-517. [Chen C, Liu H, Lin YG, et al. Research progress on the role of sarcopenia in the pathogenesis of atherosclerotic cardio-cerebrovascular disease in the elderly[J]. Medical Journal of Chinese People's Liberation Army, 2021, 46(5): 512-517.] DOI: 10.11855/j.issn.0577-7402.2021.05.14.
3.李娜,王娅鑫,雷青,等. 社区老年肌少症筛查工具准确性的网状Meta分析[J]. 中国循证医学杂志, 2024, 24(6): 678-685. [Li N, Wang YX, Lei Q, et al. Accuracy of screening tools for sarcopenia in the elderly in community:a network Meta-analysis[J]. Chinese Journal of Evidence-Based Medicine, 2024, 24(6): 678-685.] DOI: 10.7507/1672-2531.202308056.
4.Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis[J]. Age Ageing, 2019, 48(4): 16-31. DOI: 10.1093/ageing/afz046.
5.Chen LK, Woo J, Assantachai P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc, 2020, 21(3): 300-307. DOI: 10.1016/j.jamda.2019.12.012.
6.崔华,王朝晖,吴剑卿,等. 老年人肌少症防控干预中国专家共识(2023)[J]. 中华老年医学杂志, 2023, 42(2): 144-153. [Cui H, Wang ZH, Wu JQ, et al. Chinese expert consensus on prevention and intervention for eldly with scropenia(2023) [J]. Chinese Journal of Geriatrics, 2023, 42(2): 144-153.] DOI: 10.3760/cma.j.issn.0254-9026.2023.02.002.
7.Boon AJ, Wijntjes J, O'Brien TG, et al. Diagnostic accuracy of gray scale muscle ultrasound screening for pediatric neuromuscular disease[J]. Muscle Nerve, 2021, 64(1): 50-58. DOI: 10.1002/mus.27211.
8.Rolland Y, Lauwers-Cances V, Cristini C, et al. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) Study[J]. Am J Clin Nutr, 2009, 89(6): 1895-1900. DOI: 10.3945/ajcn.2008.26950.
9.Schaap LA, Koster A, Visser M. Adiposity, muscle mass, and muscle strength in relation to functional decline in older persons[J]. Epidemiol Rev, 2013, 35: 51-65. DOI: 10.1093/epirev/mxs006.
10.Bastijns S, De Cock AM, Vandewoude M, et al. Usability and pitfalls of shear-wave elastography for evaluation of muscle quality and its potential in assessing sarcopenia: a review[J]. Ultrasound Med Biol, 2020, 46(11): 2891-2907. DOI: 10.1016/j.ultrasmedbio.2020.06.023.
11.Smith E, Azzopardi C, Thaker S, et al. Power Doppler in musculoskeletal ultrasound: uses, pitfalls and principles to overcome its shortcomings[J]. J Ultrasound, 2021, 24(2): 151-156. DOI: 10.1007/s40477-020-00489-0.
12.刘娟,丁清清,周白瑜,等. 中国老年人肌少症诊疗专家共识(2021)[J]. 中华老年医学杂志, 2021, 40(8): 943-952. [Liu J, Ding QQ, Zhou BY, et al. Chinese expert consensus on diagnosis and treatment for eldly with scropenia (2021) [J]. Chinese Journal of Geriatrics, 2021, 40(8): 943-952.] DOI: 10.3760/cma.j.issn.0254-9026.2021.08.001.
13.Dietz AR, Connolly A, Dori A, et al. Intramuscular blood flow in duchenne and becker muscular dystrophy: quantitative power doppler sonography relates to disease severity[J]. Clin Neurophysiol, 2020, 131(1): 1-5. DOI: 10.1016/j.clinph.2019.09.023.
14.Kuschel LB, Sonnenburg D, Engel T. Factors of muscle quality and determinants of muscle strength: a systematic literature review[J]. Healthcare (Basel), 2022, 10(10): 1937. DOI: 10.3390/healthcare10101937.
15.崔梦钊, 刚晓坤, 崔发英,等. 肌少症影像学诊断方法及生物学标志[J]. 中华骨质疏松和骨矿盐疾病杂志, 2018, 11(4): 415-422. [Cui MZ, Gang XK, Cui FY, et al. Imaging diagnostic methods and biological markers of sarcopenia[J]. Chinese Journal of Osteoporosis and Bone Mineral Research, 2018, 11(4): 415-422.] DOI: 10.3969/j.issn.1674-2591.2018.04.015.
16.Ticinesi A, Meschi T, Narici MV, et al. Muscle ultrasound and sarcopenia in older individuals: a clinical perspective[J]. J Am Med Dir Assoc, 2017, 18(4): 290-300. DOI: 10.1016/j.jamda.2016.11.013.
17.Li S, Li H, Hu Y, et al. Ultrasound for measuring the cross-sectional area of biceps brachii muscle in sarcopeni[J]. Int J Med Sci, 2020, 17(18): 2947-2953. DOI: 10.7150/ijms.49637.
18.Hida T, Ando K, Kobayashi K, et al. Ultrasound measurement of thigh muscle thickness for assessment of sarcopenia[J]. Nagoya J Med Sci, 2018, 80(4): 519-527. DOI: 10.18999/nagjms.80.4.519.
19.Vale-Lira A, Turri-Silva N, Verboven K, et al. Muscle-skeletal abnormalities and muscle oxygenation during isokinetic strength exercise in heart failure with preserved ejection fraction phenotype: a cross-sectional study[J]. Int J Environ Res Public Health, 2022, 19(2): 709. DOI: 10.3390/ijerph19020709.
20.Gliemann L, Mortensen SP, Hellsten Y. Methods for the determination of skeletal muscle blood flow: development, strengths and limitations[J]. Eur J Appl Physiol, 2018, 118(6): 1081-1094. DOI: 10.1007/s00421-018-3880-5.
21.Babaei S, Dobrucki LW, Insana MF. Power-doppler ultrasonic imaging of peripheral perfusion in diabetic mice[J]. IEEE Trans Biomed Eng, 2024, 71(8): 2421-2431. DOI: 10.1109/TBME.2024.3373254.
22.Taljanovic MS, Gimber LH, Becker GW, et al. Shear-Wave elastography: basic physics and musculoskeletal applications[J]. Radiographics, 2017, 37(3): 855-870. DOI: 10.1148/rg.2017160116.
23.Sibbitt WL Jr, Sibbitt RR. Sonoelastography: a powerful technique in musculoskeletal imaging[J]. J Clin Ultrasound, 2023, 51(1): 131-133. DOI: 10.1002/jcu.23353.
24.Garatachea N, Lucia A. Genes, physical fitness and ageing[J]. Ageing Res Rev, 2013, 12(1): 90-102. DOI: 10.1016/j.arr.2012.09.003.
25.Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases[J]. Lancet Diabetes Endocrinol, 2014, 2(10): 819-829. DOI: 10.1016/S2213-8587(14)70034-8.